Elaine Chow1,2,3, Juliana C N Chan4,5,6. 1. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China. 2. Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China. 3. Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China. 4. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China. jchan@cuhk.edu.hk. 5. Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China. jchan@cuhk.edu.hk. 6. Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China. jchan@cuhk.edu.hk.
Authors: Jonathan M Wilson; Yanzhu Lin; M Jane Luo; Gary Considine; Amy L Cox; Lenden M Bowsman; Deborah A Robins; Axel Haupt; Kevin L Duffin; Giacomo Ruotolo Journal: Diabetes Obes Metab Date: 2021-10-11 Impact factor: 6.408